"that October, the FDA issued a complete response letter for the same candidate in a different indication, pediatric acute graft-versus-host disease, over issues with trial design. Mesoblast had submitted its application on the basis of one single-arm, open-label study rather than a randomized trial, even though the drug demonstrated a statistically significant benefit in its primary endpoint against the historical control rate."
have to be remember..... well atleast the FDA should they advised and agreed with the single arm. and as said by many here ...the FDA changed the goal posts after admin stuff ups
- Forums
- ASX - By Stock
- MSB
- Ann: Update on Novartis Agreement
Ann: Update on Novartis Agreement, page-599
-
-
- There are more pages in this discussion • 252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
90.5¢ |
Change
0.020(2.26%) |
Mkt cap ! $1.033B |
Open | High | Low | Value | Volume |
88.5¢ | 95.0¢ | 88.0¢ | $5.610M | 6.115M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 317774 | 90.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
91.5¢ | 23500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 317774 | 0.900 |
3 | 102940 | 0.895 |
9 | 43375 | 0.890 |
2 | 15799 | 0.885 |
9 | 97463 | 0.880 |
Price($) | Vol. | No. |
---|---|---|
0.915 | 23500 | 2 |
0.920 | 20000 | 1 |
0.925 | 72140 | 4 |
0.930 | 73187 | 3 |
0.935 | 40328 | 1 |
Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
MSB (ASX) Chart |